Innsbruck Health Promotion Program
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVASCage GmbH
About this trial
The primary goal of this single-centre. single-arm, unblinded, pre-post interventional study is to evaluate whether a one-time health assessment and intervention affects the overall vascular health evaluated through the Life's Essential 8 overall vascular health score.
Secondary goals of this study are, among others:
* to describe incidence and prevalence of vascular risk-factors and behaviours * to explore prevalence and associations of health and disease in the general population with special focus on cardiovascular risk, cardiovascular diseases, markers of vascular health, signs and (prodromal) symptoms of neurodegeneration as well as psychosocial factors * to explore the prevalence of hearing disorders in the general population * to collect voice and speech samples to identify novel biomarkers that correlate to vascular health and/or hearing status
Eligibility criteria
Qualifiers
Signed informed consent of subject
Main area of residence in Innsbruck and Innsbruck-Land
Disqualifiers
People who are suspended upon a court order or upon other legal processes or are accommodated according ot the Hospitalization Act, or for whom a custodian is appointed (or appointment is inititated)
Persons with impaired power of judgement
Persons who are currently engaged in military or community service
Trial design
Treatments tested in this trial
- In-person health promotion
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
VASCage GmbH
Lead sponsor
Oroboros Instruments
Collaborator
Med-El Corporation
Collaborator
Tirol Kiniken GmbH
Collaborator
Österreichische Gesundheitskasse
Collaborator
Source ClinicalTrials.gov